-
IBRN Dashboard
- Holdings
iShares Neuroscience and Healthcare ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares | 475.76 k | 475.43 k shares | 11.87 | Short-term investment vehicle | Long | USA |
Biohaven Ltd
|
195.21 k | 3.92 k shares | 4.87 | Common equity | Long | Virgin Islands (British) |
PTCT PTC Therapeutics, Inc. | 183.23 k | 4.59 k shares | 4.57 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 166.87 k | 1.97 k shares | 4.16 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 159.21 k | 7.30 k shares | 3.97 | Common equity | Long | USA |
SK Biopharmaceuticals Co Ltd
|
156.79 k | 1.85 k shares | 3.91 | Common equity | Long | Korea, Republic of |
ARGX argenx SE | 156.54 k | 267.00 shares | 3.91 | Common equity | Long | Netherlands |
XENE Xenon Pharmaceuticals Inc. | 154.70 k | 3.76 k shares | 3.86 | Common equity | Long | Canada |
AXNX Axonics, Inc. | 147.91 k | 2.10 k shares | 3.69 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 144.93 k | 1.21 k shares | 3.62 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 142.61 k | 2.39 k shares | 3.56 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 141.50 k | 1.12 k shares | 3.53 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 139.68 k | 4.16 k shares | 3.48 | Common equity | Long | USA |
Alkermes PLC
|
138.52 k | 5.39 k shares | 3.46 | Common equity | Long | Ireland |
SRRK Scholar Rock Holding Corporation | 132.62 k | 4.66 k shares | 3.31 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 131.46 k | 9.01 k shares | 3.28 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 128.27 k | 3.77 k shares | 3.20 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 126.49 k | 4.38 k shares | 3.16 | Common equity | Long | USA |
BIIB Biogen Inc. | 125.45 k | 721.00 shares | 3.13 | Common equity | Long | USA |
H Lundbeck A/S
|
124.53 k | 19.12 k shares | 3.11 | Common equity | Long | Denmark |
Avadel Pharmaceuticals PLC
|
99.75 k | 6.45 k shares | 2.49 | Common equity | Long | Ireland |
IART Integra LifeSciences Holdings Corporation | 87.12 k | 4.64 k shares | 2.17 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 81.68 k | 1.17 k shares | 2.04 | Common equity | Long | USA |
SAVA Cassava Sciences, Inc. | 78.03 k | 3.02 k shares | 1.95 | Common equity | Long | USA |
Neuren Pharmaceuticals Ltd
|
64.58 k | 8.02 k shares | 1.61 | Common equity | Long | New Zealand |
Prothena Corp PLC
|
56.34 k | 3.31 k shares | 1.41 | Common equity | Long | Ireland |
ANNX Annexon, Inc. | 43.83 k | 5.99 k shares | 1.09 | Common equity | Long | USA |
CAPR Capricor Therapeutics, Inc. | 42.53 k | 2.12 k shares | 1.06 | Common equity | Long | USA |
AXGN AxoGen, Inc. | 41.29 k | 2.95 k shares | 1.03 | Common equity | Long | USA |
DNTH Dianthus Therapeutics, Inc. | 39.90 k | 1.43 k shares | 1.00 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 38.81 k | 5.86 k shares | 0.97 | Common equity | Long | USA |
BioArctic AB
|
38.47 k | 2.78 k shares | 0.96 | Common equity | Long | Sweden |
NGNE Neurogene Inc. | 32.26 k | 733.00 shares | 0.80 | Common equity | Long | USA |
RAPP Rapport Therapeutics, Inc. Common Stock | 31.45 k | 1.28 k shares | 0.78 | Common equity | Long | USA |
ZVRA Zevra Therapeutics, Inc. | 30.35 k | 3.72 k shares | 0.76 | Common equity | Long | USA |
ALEC Alector, Inc. | 26.68 k | 5.42 k shares | 0.67 | Common equity | Long | USA |
TRDA Entrada Therapeutics, Inc. | 26.36 k | 1.54 k shares | 0.66 | Common equity | Long | USA |
SGMO Sangamo Therapeutics, Inc. | 24.13 k | 14.19 k shares | 0.60 | Common equity | Long | USA |
SanBio Co Ltd
|
22.91 k | 3.50 k shares | 0.57 | Common equity | Long | Japan |
VYGR Voyager Therapeutics, Inc. | 22.02 k | 3.22 k shares | 0.55 | Common equity | Long | USA |
LRMR Larimar Therapeutics, Inc. | 21.88 k | 2.66 k shares | 0.55 | Common equity | Long | USA |
CLPT ClearPoint Neuro, Inc. | 21.17 k | 1.71 k shares | 0.53 | Common equity | Long | USA |
Medincell SA
|
20.87 k | 1.27 k shares | 0.52 | Common equity | Long | France |
TSHA Taysha Gene Therapies, Inc. | 19.02 k | 11.25 k shares | 0.47 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc. | 18.32 k | 3.94 k shares | 0.46 | Common equity | Long | USA |
ABEO Abeona Therapeutics Inc. | 17.81 k | 2.78 k shares | 0.44 | Common equity | Long | USA |
CTNM Contineum Therapeutics, Inc. Class A Common Stock | 16.93 k | 1.01 k shares | 0.42 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals, Inc. | 15.87 k | 2.94 k shares | 0.40 | Common equity | Long | USA |
MicroPort NeuroScientific Corp
|
15.70 k | 13.00 k shares | 0.39 | Common equity | Long | Cayman Islands |
Peijia Medical Ltd
|
15.47 k | 31.00 k shares | 0.39 | Common equity | Long | Cayman Islands |
CLYM Climb Bio, Inc. | 14.14 k | 3.70 k shares | 0.35 | Common equity | Long | USA |
NVRO Nevro Corp. | 13.55 k | 2.46 k shares | 0.34 | Common equity | Long | USA |
SLDB Solid Biosciences Inc. | 12.96 k | 2.35 k shares | 0.32 | Common equity | Long | USA |
PEPG PepGen Inc. | 12.15 k | 1.84 k shares | 0.30 | Common equity | Long | USA |
Cellivery Therapeutics Inc
|
11.22 k | 3.57 k shares | 0.28 | Common equity | Long | Korea, Republic of |
Idorsia Ltd
|
9.79 k | 8.62 k shares | 0.24 | Common equity | Long | Switzerland |
ABOS Acumen Pharmaceuticals, Inc. | 9.27 k | 3.22 k shares | 0.23 | Common equity | Long | USA |
ANRO Alto Neuroscience, Inc. | 6.15 k | 1.58 k shares | 0.15 | Common equity | Long | USA |